Jessica Sabbath// June 25, 2018//
A United Kingdom clinic focused on the diagnosis and care of cognitive disabilities is expanding to the U.S. and will open its first clinic in Fairfax County.
Re:Cognition Health’s Fairfax clinic will focus on Alzheimer’s Disease and dementia-related services.
Dr. James Bicksel, a neurologist who also sits on the board of directors for the Alzheimer’s Association and is the medical director of the Inova Memory Center, will lead the clinical trial team.
“We are excited to expand Re:Cognition Health’s centers into the USA, allowing for the opportunity for more people to gain access to the most advanced treatments available worldwide,” Dr. Emer MacSweeney, CEO and medical director of Re:Cognition Health, said in a statement.
Re:Cognition Health expects to employ 25 people within three years and invest several million dollars at the Fairfax facility.
Re:Cognition Health conducts international final phase clinical trials. With more than 140,000 people living with a diagnosis of mild cognitive impairment or dementia in Virginia, Re:Cognition Health’s Fairfax clinic will support patients with memory loss and other symptoms of cognitive impairment with education, treatment and access to advanced treatments.
Re:Cognition Health and the Fairfax County Economic Development Authority (FCEDA) made the announcement last week at the 2018 SelectUSA Summit presented by the U.S. Department of Commerce to promote foreign direct investment in the United States.
Re:Cognition Health specializes in the diagnosis, treatment and care of people showing symptoms of cognitive impairment or mental health concerns. Clinical services include traumatic brain injury, neurology, children’s neurological conditions, Alzheimer’s and dementia and mental health.
s